Catalyst Wire Dossier Catalyst Wire Dossier

Glyxambi 25 mg/5 mg Film-coated Tablets

empagliflozin/linagliptin · Boehringer Ingelheim; Eli Lilly
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Glyxambi 25 mg/5 mg Film-coated Tablets, covering 2025-04-17 to 2025-04-17. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Study to Compare Empagliflozin + Linagliptin 25 mg/5 mg Film-coated Tablets Versus Glyxambi 25 mg/ 5 mg Film-coated Tablets [Phase 1]

See pricing